A detailed history of Mc Clarren Financial Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Mc Clarren Financial Advisors, Inc. holds 216 shares of ZTS stock, worth $38,169. This represents 0.01% of its overall portfolio holdings.

Number of Shares
216
Previous 520 58.46%
Holding current value
$38,169
Previous $37,000 13.51%
% of portfolio
0.01%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$172.58 - $196.48 $52,464 - $59,729
-304 Reduced 58.46%
216 $42,000
Q2 2024

Jul 26, 2024

BUY
$145.54 - $178.83 $44,244 - $54,364
304 Added 140.74%
520 $37,000
Q1 2024

Jul 26, 2024

SELL
$165.67 - $199.94 $48,375 - $58,382
-292 Reduced 57.48%
216 $37,000
Q1 2024

May 03, 2024

BUY
$165.67 - $199.94 $48,541 - $58,582
293 Added 136.28%
508 $37,000
Q4 2023

Feb 02, 2024

BUY
$151.44 - $200.09 $151 - $200
1 Added 0.47%
215 $42,000
Q2 2023

Aug 04, 2023

BUY
$160.94 - $186.23 $160 - $186
1 Added 0.47%
214 $36,000
Q4 2022

Jan 30, 2023

BUY
$131.14 - $157.47 $393 - $472
3 Added 1.43%
213 $31,000
Q3 2022

Oct 31, 2022

BUY
$148.29 - $182.55 $31,140 - $38,335
210 New
210 $31,000
Q2 2022

Aug 11, 2022

SELL
$155.97 - $200.09 $32,753 - $42,018
-210 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$181.39 - $234.03 $181 - $234
-1 Reduced 0.47%
210 $39,000
Q4 2021

Jan 19, 2022

BUY
$193.69 - $247.03 $387 - $494
2 Added 0.96%
211 $52,000
Q3 2021

Oct 15, 2021

BUY
$189.29 - $209.69 $12,303 - $13,629
65 Added 45.14%
209 $40,000
Q1 2021

Apr 21, 2021

BUY
$144.0 - $169.39 $144 - $169
1 Added 0.7%
144 $23,000
Q4 2020

Jan 29, 2021

BUY
$157.07 - $174.35 $22,461 - $24,932
143 New
143 $23,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Mc Clarren Financial Advisors, Inc. Portfolio

Follow Mc Clarren Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.